ICOS and neoplasm: There appeared to be a concomitant increase in the absolute Tfh numbers in these tumours (defined by CD4+FoxP3-CXCR5+PD-1+ICOS+ lineage), although the relative percentage of these cells remained low and not substantially different from the other treatment groups (Fig. 6b).